Drug intelligence / Profile preview

Erbiqing

Development stage
Unknown
Lead developer
Anhui Institute of Materia Medica
Modality
Small Molecules
Administration
Oral
01

Overview

Erbiqing is a Traditional Chinese Medicine (TCM) granule formulation developed by the Anhui Institute of Pharmaceutical Research for the treatment of acute secretory otitis media (ASOM). The preparation is composed of several herbal ingredients, including *Scutellaria baicalensis* and *Bupleurum chinense*, which are traditionally used to clear heat and resolve dampness. In the context of secretory otitis media, Erbiqing is intended to reduce inflammation and edema in the Eustachian tube and middle ear mucosa, thereby promoting the absorption and drainage of middle ear effusion. Clinical studies have indicated that Erbiqing can lower the levels of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6 in the middle ear effusion, which are key mediators in the pathogenesis of ASOM. It is primarily used in the Chinese clinical setting as an alternative or adjunct to conventional therapies.

Brand names
Erbiqing
Other names
Erbiqing GranulesErbiqing Keli
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))IL1B (Interleukin-1 beta)IL-6 (Interleukin 6)

Beyond the preview

Go deeper on Erbiqing.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Erbiqing.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call